Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on May 23, 2025
ALRMiner Launches Smarter System to Boost Returns and Cut Energy Use
GlobeNewswire
·
May 23, 2025
Monmouth, Monmouthshire, May 23, 2025 (GLOBE NEWSWIRE) -- The platform has evolved to accommodate the needs of its growing customer base throughout the years. ALRMiner introduced their revolutionary Mining Optimization System to enhance operational …
Clip Money Inc. Reports First Quarter 2025 Results
GlobeNewswire
·
May 23, 2025
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce its financial results for the …
Tilray Medical bringt die bekannte kanadische Cannabismarke Good Supply nach Deutschland
GlobeNewswire
·
May 23, 2025
NEUMÜNSTER, Deutschland, May 23, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führendes Unternehmen im Bereich des medizinischen Cannabis, das die …
Tilray Medical introduit Good Supply, la marque emblématique de cannabis canadienne, en Allemagne
GlobeNewswire
·
May 23, 2025
NEUMÜNSTER, Allemagne, 23 mai 2025 (GLOBE NEWSWIRE) -- Tilray Medical (« Tilray »), une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de …
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 23, 2025
Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a First-in-Class In Situ Personalized Immunotherapy Platform Abstract published on podium presentation that will take place during the “Developmental …
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 23, 2025
SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today …
IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer
GlobeNewswire
·
May 23, 2025
Data show continuous clinically significant improvement, with median 13-month and 3-month increases in overall and progression-free survival, respectively, in treatment group Women treated with IMNN-001 and standard of care chemotherapy plus PARP …
Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025
GlobeNewswire
·
May 23, 2025
COPENHAGEN, Denmark, May 23, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its first quarter 2025 financial results on …
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 23, 2025
SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the Jefferies Global Healthcare Conference, taking place June 3-5, 2025 in New York, NY. Jefferies …
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
GlobeNewswire
·
May 23, 2025
– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for both adults and children with NF1-PN – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, …
As Bitcoin Price Soars to $110,000, XRP and Dogecoin Whale Investors Turn to XY Miners Cloud Mining
GlobeNewswire
·
May 23, 2025
Los Angeles, CA, May 23, 2025 (GLOBE NEWSWIRE) -- As Bitcoin price skyrockets past $110,000 in 2025, a new wave of crypto momentum is sweeping across the market. Whale investors in XRP and Dogecoin are shifting their strategies, turning away from …
XRP News: As Bitcoin & Ethereum Rally, Investors Flock To XpFinance, The First Lending & Borrowing Platform On The $XRP Ledger
GlobeNewswire
·
May 23, 2025
VILNIUS, Lithuania, May 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin has hit its all time high and Ethereum poised to break new yearly highs as the broader crypto market is awash in fresh liquidity. While notable altcoins gain the headlines, an emerging project on …
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
GlobeNewswire
·
May 23, 2025
Phase 2 survival and clinical benefit data meet or exceed outcomes of FDA-approved therapies in comparable metastatic breast cancer patients, with no treatment-related discontinuations Successful completion of the pivotal Phase 3 study may support …
Dogecoin Investors Use A Top Cloud Mining Firm, Zaminer, To Make Money Daily
GlobeNewswire
·
May 23, 2025
London, UK, May 23, 2025 (GLOBE NEWSWIRE) -- In the latest turn of political controversy, the Trump administration has asked the U.S. Supreme Court to block court orders. These orders require the Department of Government Efficiency (DOGE), a central part …
As Bitcoin Hits New All-Time Highs, DN Miner Says It’s the Perfect Time to Add Cloud Mining to Your Strategy
GlobeNewswire
·
May 23, 2025
London, UK, May 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin has once again surged past its all-time high, reigniting excitement across the crypto market and sending investor confidence soaring. But while many are celebrating record-breaking gains, DN Miner, a …
Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
GlobeNewswire
·
May 23, 2025
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …
Phunware Showcases Next-Gen Guest Experience Technology at HITEC 2025
GlobeNewswire
·
May 23, 2025
Phunware to Debut Hospitality AI Features to Streamline Mobile Interactions; Joins Industry Leaders in Discussing How Next-Gen Apps Are Redefining Guest Engagement AUSTIN, Texas, May 23, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN), a leading …
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
GlobeNewswire
·
May 23, 2025
DALLAS and SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil") and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, “ImmuneOnco”), today announced that they will jointly host an investor and research …
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
GlobeNewswire
·
May 23, 2025
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
GlobeNewswire
·
May 23, 2025
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an …